 |
Prescription and Over-the-Counter Drug Product List - 18th Edition
Cumulative Supplement Number 6: June 1998
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE CAPTOPRIL; HYDROCHLOROTHIAZIDE
TABLET; ORAL TABLET; ORAL
OXYCODONE AND ACETAMINOPHEN CAPOZIDE 25/15
> ADD > AA DURAMED 325MG;5MG N40272 001 > ADD > AB BRISTOL MYERS SQUIBB 25MG;15MG N18709 001
> ADD > JUN 30, 1998 > ADD > OCT 12, 1984
> DLT > AB SQUIBB 25MG;15MG N18709 001
> DLT > OCT 12, 1984
ADENOSINE CAPOZIDE 25/25
> ADD > AB + BRISTOL MYERS SQUIBB 25MG;25MG N18709 002
INJECTABLE; INJECTION > ADD > OCT 12, 1984
ADENOCARD > DLT > AB + SQUIBB 25MG;25MG N18709 002
> ADD > + FUJISAWA HLTHCARE 3MG/ML N19937 002 > DLT > OCT 12, 1984
> ADD > OCT 30, 1989 CAPOZIDE 50/15
> DLT > + MEDCO RES 3MG/ML N19937 002 > ADD > AB + BRISTOL MYERS SQUIBB 50MG;15MG N18709 004
> DLT > OCT 30, 1989 > ADD > OCT 12, 1984
ADENOSCAN > DLT > AB + SQUIBB 50MG;15MG N18709 004
> ADD > + FUJISAWA HLTHCARE 3MG/ML N20059 001 > DLT > OCT 12, 1984
> ADD > MAY 18, 1995 CAPOZIDE 50/25
> DLT > + MEDCO RES 3MG/ML N20059 001 > ADD > AB BRISTOL MYERS SQUIBB 50MG;25MG N18709 003
> DLT > MAY 18, 1995 > ADD > OCT 12, 1984
> DLT > AB SQUIBB 50MG;25MG N18709 003
> DLT > OCT 12, 1984
ALBUTEROL SULFATE CAPTOPRIL AND HYDROCHLOROTHIAZIDE
> ADD > AB ZENITH GOLDLINE 25MG;15MG N75055 001
SOLUTION; INHALATION > ADD > JUN 18, 1998
ALBUTEROL SULFATE > ADD > AB 25MG;25MG N75055 002
> ADD > AN BAUSCH AND LOMB EQ 0.5% BASE N75050 001 > ADD > JUN 18, 1998
> ADD > JUN 18, 1998 > ADD > AB 50MG;15MG N75055 004
> ADD > JUN 18, 1998
> ADD > AB 50MG;25MG N75055 003
> ADD > CANDESARTAN CILEXETIL > ADD > JUN 18, 1998
> ADD > TABLET; ORAL
> ADD > ATACAND CEFTIZOXIME SODIUM
> ADD > ASTRA MERCK 4MG N20838 001
> ADD > JUN 04, 1998 INJECTABLE; INJECTION
> ADD > 8MG N20838 002 CEFIZOX
> ADD > JUN 04, 1998 > DLT > + FUJISAWA EQ 500MG BASE/VIAL N50560 001
> ADD > 16MG N20838 003 > DLT > SEP 15, 1983
> ADD > JUN 04, 1998 > DLT > + EQ 1GM BASE/VIAL N50560 002
> ADD > + 32MG N20838 004 > DLT > SEP 15, 1983
> ADD > JUN 04, 1998 > DLT > + EQ 2GM BASE/VIAL N50560 003
> DLT > SEP 15, 1983
> DLT > EQ 10GM BASE/VIAL N50560 005
> DLT > MAR 19, 1993
> ADD > + FUJISAWA HLTHCARE EQ 500MG BASE/VIAL N50560 001
> ADD > SEP 15, 1983
CEFTIZOXIME SODIUM DAUNORUBICIN HYDROCHLORIDE
INJECTABLE; INJECTION INJECTABLE; INJECTION
CEFIZOX DAUNORUBICIN HCL PRESERVATIVE FREE
> ADD > + FUJISAWA HLTHCARE EQ 1GM BASE/VIAL N50560 002 > ADD > AP GENSIA SICOR PHARMS EQ 20MG BASE/VIAL N64212 001
> ADD > SEP 15, 1983 > ADD JUN 23, 1998
> ADD > + EQ 2GM BASE/VIAL N50560 003
> ADD > SEP 15, 1983
> ADD > EQ 10GM BASE/VIAL N50560 005 DISOPYRAMIDE PHOSPHATE
> ADD > MAR 19, 1993
CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER CAPSULE, EXTENDED RELEASE; ORAL
> DLT > @ FUJISAWA EQ 40MG BASE/ML N50589 002 DISOPYRAMIDE PHOSPHATE
> DLT > OCT 03, 1984 > DLT > @ KV PHARM EQ 100MG BASE N71929 001
> ADD > @ FUJISAWA HLTHCARE EQ 40MG BASE/ML N50589 002 > DLT > AUG 19, 1988
> ADD > OCT 03, 1984
CEFIZOX IN PLASTIC CONTAINER
> DLT > + FUJISAWA EQ 20MG BASE/ML N50589 003 DOBUTAMINE HYDROCHLORIDE
> DLT > APR 13, 1995
> DLT > + EQ 40MG BASE/ML N50589 004 INJECTABLE; INJECTION
> DLT > APR 13, 1995 DOBUTAMINE HCL
> ADD > + FUJISAWA HLTHCARE EQ 20MG BASE/ML N50589 003 > ADD > AP LUITPOLD EQ 12.5MG BASE/ML N74545 001
> ADD > APR 13, 1995 > ADD > JUN 25, 1998
> ADD > + EQ 40MG BASE/ML N50589 004
> ADD > APR 13, 1995
DYPHYLLINE
CEPHALEXIN > DLT > INJECTABLE; INJECTION
> DLT > NEOTHYLLINE
CAPSULE; ORAL > DLT > + TEVA 250MG/ML N09088 001
CEPHALEXIN > ADD > @ 250MG/ML N09088 001
> ADD > AB ZENITH GOLDLINE EQ 250MG BASE N61969 001
> ADD > AB EQ 500MG BASE N61969 002
> DLT > AB ZENITH LABS EQ 250MG BASE N61969 001 ERYTHROMYCIN ETHYLSUCCINATE
> DLT > AB EQ 500MG BASE N61969 002
SUSPENSION; ORAL
ERYTHROMYCIN ETHYLSUCCINATE
CIMETIDINE > DLT > @ KV PHARM EQ 200MG BASE/5ML N62047 001
> DLT > @ EQ 400MG BASE/5ML N62047 002
SOLUTION; ORAL
CIMETIDINE HCL
> ADD > AA DURAMED 300MG/5ML N75110 001 ESTRADIOL VALERATE
> ADD > JUN 18, 1998
INJECTABLE; INJECTION
DELESTROGEN
DAUNORUBICIN HYDROCHLORIDE > ADD > AO + BRISTOL MYERS SQUIBB 20MG/ML N09402 004
> ADD > AO + 40MG/ML N09402 003
INJECTABLE; INJECTION > ADD > + 10MG/ML N09402 002
DAUNORUBICIN HCL PRESERVATIVE FREE > DLT > AO + SQUIBB 20MG/ML N09402 004
> ADD > AP + BEDFORD EQ 20MG BASE/VIAL N50731 001 > DLT > AO + 40MG/ML N09402 003
> ADD > JAN 30, 1998
ESTRADIOL VALERATE HEPARIN SODIUM
INJECTABLE; INJECTION INJECTABLE; INJECTION
DELESTROGEN > ADD > HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5%
> DLT > + SQUIBB 10MG/ML N09402 002 > ADD > @ ABBOTT 5,000 UNITS/100ML N18911 007
> ADD > JAN 30, 1985
HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% IN PLASTIC
> ADD > GLUCAGON HYDROCHLORIDE RECOMBINANT CONTAINER
> DLT > AP ABBOTT 5,000 UNITS/100ML N19339 001
> ADD > INJECTABLE; INJECTION > DLT > MAR 27, 1985
> ADD > GLUCAGEN > ADD > 5,000 UNITS/100ML N19339 001
> ADD > + NOVO NORDISK EQ 1MG BASE/VIAL N20918 001 > ADD > MAR 27, 1985
> ADD > JUN 22, 1998 > DLT > HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5%
> DLT > AP ABBOTT 5,000 UNITS/100ML N18911 009
> DLT > JAN 30, 1985
GLYBURIDE > DLT > AP 10,000 UNITS/100ML N18911 008
> DLT > JAN 30, 1985
TABLET; ORAL > ADD > @ 5,000 UNITS/100ML N18911 009
GLYBURIDE (MICRONIZED) > ADD > JAN 30, 1985
> ADD > AB INVAMED 1.5MG N75174 001 > ADD > @ 10,000 UNITS/100ML N18911 008
> ADD > JUN 22, 1998 > ADD > JAN 30, 1985
> ADD > AB 3MG N75174 002
> ADD > JUN 22, 1998
> ADD > AB MYLAN 1.5MG N74792 001 HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
> ADD > JUN 26, 1998
> ADD > AB 3MG N74792 002 TABLET; ORAL
> ADD > JUN 26, 1998 SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
> ADD > AB GENEVA PHARMS 25MG;25MG N86881 001
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
GRANISETRON HYDROCHLORIDE > DLT > AB GENEVA PHARMS 25MG;25MG N86881 001
TABLET; ORAL
KYTRIL LIDOCAINE
> ADD > @ SMITHKLINE BEECHAM EQ 2MG BASE N20305 002
> ADD > JUN 15, 1998 DISC; ORAL
XYLOCAINE
> DLT > ASTRA 10% N14394 001
HEPARIN SODIUM > ADD > + 10% N14394 001
INJECTABLE; INJECTION
> DLT > HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% LIDOCAINE HYDROCHLORIDE
> DLT > AP ABBOTT 10,000 UNITS/100ML N18911 006
> DLT > JAN 30, 1985 INJECTABLE; INJECTION
> ADD > @ 10,000 UNITS/100ML N18911 006 LIDOCAINE HCL
> ADD > JAN 30, 1985 > ADD > AP AM PHARM PARTNERS 2% N17584 001
> DLT > HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% > ADD > AP 4% N17584 002
> DLT > AP ABBOTT 5,000 UNITS/100ML N18911 007 > DLT > AP FUJISAWA 2% N17584 001
> DLT > JAN 30, 1985 > DLT > AP 4% N17584 002
LISINOPRIL PAROMOMYCIN SULFATE
TABLET; ORAL CAPSULE; ORAL
ZESTRIL PAROMOMYCIN SULFATE
> DLT > AB + ZENECA 2.5MG N19777 005 > ADD > AA CARACO EQ 250MG BASE N64171 001
> DLT > APR 29, 1993 > ADD > JUN 30, 1997
> ADD > AB 2.5MG N19777 005 > DLT > AB EQ 250MG BASE N64171 001
> ADD > APR 29, 1993 > DLT > JUN 30, 1997
> DLT > AB 10MG N19777 002
> DLT > MAY 19, 1988
> ADD > AB + 10MG N19777 002 QUINIDINE SULFATE
> ADD > MAY 19, 1988
TABLET, EXTENDED RELEASE; ORAL
QUINIDEX
MAFENIDE ACETATE > ADD > AB + ROBINS AH 300MG N12796 002
> DLT > AB + WYETH AYERST 300MG N12796 002
> ADD > POWDER FOR RECONSTITUTION; TOPICAL
> ADD > SULFAMYLON
> ADD > + MYLAN 5% N19832 003 RIFAMPIN
> ADD > JUN 05, 1998
CAPSULE; ORAL
RIFADIN
NAPROXEN > ADD > AB HOECHST MARION RSSL 150MG N62303 001
RIFAMPIN
TABLET, DELAYED RELEASE; ORAL > ADD > AB EON 150MG N64150 002
NAPROXEN > ADD > JAN 02, 1998
> ADD > AB TEVA 375MG N75227 001
> ADD > JUN 30, 1998
> ADD > AB 500MG N75227 002 > ADD > RIFAPENTINE
> ADD > JUN 30, 1998
> ADD > TABLET; ORAL
> ADD > PRIFTIN
NYSTATIN > ADD > + HOECHST MARION RSSL 150MG N21024 001
> ADD > JUN 22, 1998
SUSPENSION; ORAL
NYSTATIN
> ADD > AA UDL 100,000 UNITS/ML N64142 001 > ADD > RIZATRIPTAN BENZOATE
> ADD > JUN 25, 1998
> ADD > TABLET; ORAL
> ADD > MAXALT
ORPHENADRINE CITRATE > ADD > MERCK EQ 5MG BASE N20864 001
> ADD > JUN 29, 1998
TABLET, EXTENDED RELEASE; ORAL > ADD > + EQ 10MG BASE N20864 002
NORFLEX > ADD > JUN 29, 1998
> ADD > AB + 3M 100MG N12157 001
> ADD > ORPHENADRINE CITRATE > ADD > TABLET, ORALLY DISINTEGRATING; ORAL
> ADD > AB INVAMED 100MG N40284 001 > ADD > MAXALT-MLT
> ADD > JUN 19, 1998 > ADD > MERCK EQ 5MG BASE N20865 001
> ADD > JUN 29, 1998
> ADD > RIZATRIPTAN BENZOATE TACROLIMUS
> ADD > TABLET, ORALLY DISINTEGRATING; ORAL INJECTABLE; INJECTION
> ADD > MAXALT-MLT PROGRAF
> ADD > + MERCK EQ 10MG BASE N20865 002 > ADD > + FUJISAWA HLTHCARE EQ 5MG BASE/ML N50709 001
> ADD > JUN 29, 1998 > ADD > APR 08, 1994
STREPTOMYCIN SULFATE TETRACYCLINE HYDROCHLORIDE
INJECTABLE; INJECTION CAPSULE; ORAL
STREPTOMYCIN SULFATE ACHROMYCIN V
> ADD > AP + PFIZER EQ 1GM BASE/VIAL N60076 001 > ADD > AB ESI LEDERLE 250MG N50278 003
> ADD > AP PHARMA TEK EQ 1GM BASE/VIAL N64210 001 > ADD > AB + 500MG N50278 001
> ADD > JUN 30, 1998 > DLT > AB LEDERLE 250MG N50278 003
> DLT > AB + 500MG N50278 001
SUCRALFATE
TRETINOIN
TABLET; ORAL
SUCRALFATE SOLUTION; TOPICAL
> ADD > AB RATIOPHARM 1GM N74415 001 RETIN-A
> ADD > JUN 08, 1998 > DLT > + J AND J 0.05% N16921 001
> ADD > AT + JOHNSON AND JOHNSON 0.05% N16921 001
> ADD > TRETINOIN
SULFACETAMIDE SODIUM > ADD > AT COPLEY PHARM 0.05% N74873 001
> ADD > JUN 19, 1998
SOLUTION/DROPS; OPHTHALMIC
> DLT > SULF-10
> DLT > AT CIBA 10% N80025 001 TRIMETHAPHAN CAMSYLATE
> ADD > @ 10% N80025 001
> DLT > INJECTABLE; INJECTION
> DLT > ARFONAD
TACROLIMUS > DLT > + ROCHE 50MG/ML N08983 001
> ADD > @ 50MG/ML N08983 001
CAPSULE; ORAL
PROGRAF
> DLT > + FUJISAWA EQ 1MG BASE N50708 001
> DLT > APR 08, 1994
> DLT > + EQ 5MG BASE N50708 002
> DLT > APR 08, 1994
> ADD > + FUJISAWA HLTHCARE EQ 1MG BASE N50708 001
> ADD > APR 08, 1994
> ADD > + EQ 5MG BASE N50708 002
> ADD > APR 08, 1994
INJECTABLE; INJECTION
PROGRAF
> DLT > + FUJISAWA EQ 5MG BASE/ML N50709 001
> DLT > APR 08, 1994
CIMETIDINE
TABLET; ORAL
> ADD > CIMETIDINE
> ADD > LEK PHARM 100MG N75122 001
> ADD > JUN 19, 1998
> ADD > 200MG N75122 002
> ADD > JUN 19, 1998
> ADD > NOVOPHARM 200MG N74961 001
> ADD > JUN 19, 1998
> ADD > PERRIGO 100MG N74972 001
> ADD > JUN 19, 1998
> ADD > PHARM FORM 200MG N74963 001
> ADD > JUN 19, 1998
> ADD > TORPHARM 100MG N74948 001
> ADD > JUN 19, 1998
Last update: July 15, 2005 |
|
